Atlas Trials

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Clinical trial NCT06014372 · UNKNOWN

Trial details

NCT number
NCT06014372
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colon CancerNeoadjuvant TherapyImmunotherapy
Start date
2023-07-01
Primary completion
2024-07-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.